RxDoctor Payments Data

Lewis Andres, MD

Plastic Surgery · Scottsdale, AZNPI 1902929508

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,690 of the $8,264 with a category attached, or 81.0%. 16 manufacturers reported payments, led by AbbVie at 39.3% of the total. Reporting peaked in 2024 at $2,163 and has fallen 80.7% since, to $417 in 2025.

$8,264in general payments, 2019–2025

Across 151 payments — averaging $54.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Mentor Worldwide LLC$3K
  • Musculoskeletal Transplant Foundation Inc.$817
  • Sientra, Inc.$591
  • Tepha Inc$234
  • Davol Inc.$149
  • plus $486 from 10 others
$184,747in research payments, 2019–2025

Across 254 payments — averaging $727.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mentor Worldwide LLC$171K
  • Medical Device Business Services, Inc.$14K

What the payments were for

  • Travel & lodging$1,57419%
  • Food & beverage$6,69081%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,264 in reported general payments places this provider in the 80th percentile of 123 plastic surgery providers in Arizona.

See all plastic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$90,213
Medicare patients
63
Services billed
239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin18$236
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$181
Ondansetron OdtOndansetron17$121

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →